欣欣宇 personal page - To The Moon

欣欣宇

欣欣宇

No personal profile

11Follow

3Followers

0Topic

0Badge

2021-09-21

$Vanguard S&P 500 ETF(VOO)$?

2021-07-22

$ARK Genomic Revolution Multi-Sector ETF(ARKG)$._. Have been holding since last year

2021-07-09

Nice

Sorry, the original content has been removed

2021-07-09

Oh noooo

Sorry, the original content has been removed

2021-07-09

Kkkk

GameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report

2021-07-09

Good

Sorry, the original content has been removed

2021-07-06

$Alibaba(BABA)$Fml

2021-07-02

$Alibaba(BABA)$Sobs

2021-07-02

$ARK Genomic Revolution Multi-Sector ETF(ARKG)$Have been holding since Feb

2021-06-26

$ARK Genomic Revolution Multi-Sector ETF(ARKG)$LOLOL finally less than 10%

2021-06-26

Wow

Sorry, the original content has been removed

2021-04-30

Nice

Sorry, the original content has been removed

2021-04-30

Nice

Sorry, the original content has been removed

2021-04-30

Nice

Sorry, the original content has been removed

2021-04-30

Nice

3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street

2021-04-30

Nice

Sorry, the original content has been removed

2021-04-29

$ARK Genomic Revolution Multi-Sector ETF(ARKG)$wth is wrong w this

2021-04-28

$ARK Genomic Revolution Multi-Sector ETF(ARKG)$-.-

2021-04-24

$ARK Genomic Revolution Multi-Sector ETF(ARKG)$I am worried

2021-04-24

$ARK Innovation ETF(ARKK)$Waiting for it to recover

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3560508329513236","uuid":"3560508329513236","gmtCreate":1611969546616,"gmtModify":1706620736990,"name":"欣欣宇","pinyin":"xxyxinxinyu","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":11,"tweetSize":26,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.17%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.44%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":869909710,"gmtCreate":1632232781030,"gmtModify":1676530730510,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VOO\">$Vanguard S&amp;P 500 ETF(VOO)$</a>?","listText":"<a href=\"https://laohu8.com/S/VOO\">$Vanguard S&amp;P 500 ETF(VOO)$</a>?","text":"$Vanguard S&P 500 ETF(VOO)$?","images":[{"img":"https://static.tigerbbs.com/3f37c53f199580d28bc2cf8dd6a9a33a","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869909710","isVote":1,"tweetType":1,"viewCount":320,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172289826,"gmtCreate":1626962452465,"gmtModify":1703481468254,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>._. Have been holding since last year&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>._. Have been holding since last year&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$._. Have been holding since last year","images":[{"img":"https://static.tigerbbs.com/c807337cb85ef61d9bcd70f1b3161ee3","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172289826","isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":141977194,"gmtCreate":1625837339818,"gmtModify":1703749531267,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141977194","repostId":"2150376848","repostType":4,"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141977009,"gmtCreate":1625837311701,"gmtModify":1703749530451,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Oh noooo","listText":"Oh noooo","text":"Oh noooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141977009","repostId":"2150537517","repostType":4,"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141974483,"gmtCreate":1625837295442,"gmtModify":1703749531105,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Kkkk&nbsp;","listText":"Kkkk&nbsp;","text":"Kkkk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141974483","repostId":"1113072261","repostType":4,"repost":{"id":"1113072261","pubTimestamp":1625823554,"share":"https://ttm.financial/m/news/1113072261?lang=&edition=fundamental","pubTime":"2021-07-09 17:39","market":"us","language":"en","title":"GameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1113072261","media":"Benzinga","summary":"GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of","content":"<p><b>GameStop Corp.</b>&nbsp;short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg&nbsp;reported&nbsp;Thursday, citing people familiar with the matter.</p>\n<p><b>What Happened:</b>Founded in 2014 by Gabe Plotkin, a former portfolio manager for Steve Cohen, Melvin Capital was at the heart of the GameStop saga earlier this year.</p>\n<p>The hedge fund, which managed $11 billion in assets as of June 1, is taking smaller-sized positions to limit exposure to single companies, as per the report.</p>\n<p>Plotkin has reportedly instructed his team of data scientists to watch social media and message boards to look for shares that are seeing high support from retail investors.</p>\n<p><b>Why It Matters:</b>Melvin Capital’s first-half results indicate the hedge fund is struggling to rebound from thelossesit incurred from betting against GameStop&nbsp;and other stonks - stocks popular with retail investors.</p>\n<p>Melvin Capital said in May it has&nbsp;closed out&nbsp;of all its public bearish positions in the first quarter. This included its listed put options in GameStop.</p>\n<p>It was&nbsp;reported&nbsp;in June that London-based White Square Capital is shutting down after suffering huge losses during the retail trading frenzy earlier in the year. This marked one of the first hedge fund closures following the surge in shares of stonks.</p>\n<p>In early June,<b>AMC Entertainment Holdings Inc.</b>&nbsp;and GameStop short-seller losses swelled up to$12 billionon a year-to-date basis. Both the stocks continue to seehigh interestfrom retail investors.</p>\n<p><b>Price Action</b>: AMC Entertainment shares closed almost 6.4% higher in Thursday’s regular trading session at $47.94, while GameStop shares closed almost 0.4% higher at $191.38.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 17:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg reported Thursday, citing people familiar with the matter.\nWhat Happened:Founded in ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","AMC":"AMC院线"},"source_url":"https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113072261","content_text":"GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg reported Thursday, citing people familiar with the matter.\nWhat Happened:Founded in 2014 by Gabe Plotkin, a former portfolio manager for Steve Cohen, Melvin Capital was at the heart of the GameStop saga earlier this year.\nThe hedge fund, which managed $11 billion in assets as of June 1, is taking smaller-sized positions to limit exposure to single companies, as per the report.\nPlotkin has reportedly instructed his team of data scientists to watch social media and message boards to look for shares that are seeing high support from retail investors.\nWhy It Matters:Melvin Capital’s first-half results indicate the hedge fund is struggling to rebound from thelossesit incurred from betting against GameStop and other stonks - stocks popular with retail investors.\nMelvin Capital said in May it has closed out of all its public bearish positions in the first quarter. This included its listed put options in GameStop.\nIt was reported in June that London-based White Square Capital is shutting down after suffering huge losses during the retail trading frenzy earlier in the year. This marked one of the first hedge fund closures following the surge in shares of stonks.\nIn early June,AMC Entertainment Holdings Inc. and GameStop short-seller losses swelled up to$12 billionon a year-to-date basis. Both the stocks continue to seehigh interestfrom retail investors.\nPrice Action: AMC Entertainment shares closed almost 6.4% higher in Thursday’s regular trading session at $47.94, while GameStop shares closed almost 0.4% higher at $191.38.","news_type":1},"isVote":1,"tweetType":1,"viewCount":361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141974061,"gmtCreate":1625837266653,"gmtModify":1703749529799,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141974061","repostId":"2150980376","repostType":4,"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157137043,"gmtCreate":1625571578982,"gmtModify":1703743981828,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Fml&nbsp;","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Fml&nbsp;","text":"$Alibaba(BABA)$Fml","images":[{"img":"https://static.tigerbbs.com/c4795ba762ebdf7bb475df060911a49d","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157137043","isVote":1,"tweetType":1,"viewCount":218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156743989,"gmtCreate":1625238350241,"gmtModify":1703739237136,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Sobs&nbsp;","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Sobs&nbsp;","text":"$Alibaba(BABA)$Sobs","images":[{"img":"https://static.tigerbbs.com/b899ec0eacf287348884e35b865d69c7","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156743989","isVote":1,"tweetType":1,"viewCount":286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156710833,"gmtCreate":1625236509022,"gmtModify":1703739165398,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Have been holding since Feb&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Have been holding since Feb&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$Have been holding since Feb","images":[{"img":"https://static.tigerbbs.com/570612cd6514f7b5cb9efcf94dc5c7f5","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156710833","isVote":1,"tweetType":1,"viewCount":249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125241091,"gmtCreate":1624677099313,"gmtModify":1703843431131,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>LOLOL finally less than 10%&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>LOLOL finally less than 10%&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$LOLOL finally less than 10%","images":[{"img":"https://static.tigerbbs.com/6cf16fa79e2834e2fceb5d4dd2965904","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125241091","isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125058705,"gmtCreate":1624637774207,"gmtModify":1703842566402,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Wow&nbsp;","listText":"Wow&nbsp;","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125058705","repostId":"2146079086","repostType":4,"isVote":1,"tweetType":1,"viewCount":61,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103561043,"gmtCreate":1619793893482,"gmtModify":1704272507362,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"&nbsp;Nice&nbsp;","listText":"&nbsp;Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/103561043","repostId":"1180690637","repostType":4,"isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103563501,"gmtCreate":1619793875303,"gmtModify":1704272506543,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103563501","repostId":"1189807124","repostType":4,"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103560526,"gmtCreate":1619793781265,"gmtModify":1704272503413,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103560526","repostId":"1129215602","repostType":4,"isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103587581,"gmtCreate":1619793707443,"gmtModify":1704272502269,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103587581","repostId":"1165708828","repostType":4,"repost":{"id":"1165708828","pubTimestamp":1619792862,"share":"https://ttm.financial/m/news/1165708828?lang=&edition=fundamental","pubTime":"2021-04-30 22:27","market":"us","language":"en","title":"3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1165708828","media":"Motley Fool","summary":"For more than a year, patient investors have been handsomely rewarded. All three of the market's maj","content":"<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.</p>\n<p>Yet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in the<b>S&amp;P 500</b>,<b>Dow Jones Industrial Average</b>, and<b>Nasdaq Composite</b>, this represents a huge underperformance.</p>\n<p>But according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.</p>\n<p>Sarepta Therapeutics: Implied upside of 91%</p>\n<p>Many of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developer<b>Sarepta Therapeutics</b>(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.</p>\n<p>Sarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.</p>\n<p>However, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.&nbsp; In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.</p>\n<p>The Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.</p>\n<p>Intercept Pharmaceuticals: Implied upside of 97%</p>\n<p>If you wanteven more upside potential, Wall Street would steer you toward small-cap<b>Intercept Pharmaceuticals</b>(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.</p>\n<p>Similar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.</p>\n<p>Intercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.</p>\n<p>On the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.</p>\n<p>If OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.</p>\n<p>It's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.</p>\n<p>Inovio Pharmaceuticals: Implied upside of 104%</p>\n<p>Yet another biotech stock withbig-time upside potential, according to Wall Street, is<b>Inovio Pharmaceuticals</b>(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.</p>\n<p>For much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.</p>\n<p>Unfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.</p>\n<p>There are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players like<b>Johnson &amp; Johnson</b>&nbsp;can produce up to 3 billion doses for the global market this year. As a reminder, J&amp;J's vaccine is a single-dose treatment.</p>\n<p>The other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.</p>\n<p>With a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 22:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165708828","content_text":"For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.\nYet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in theS&P 500,Dow Jones Industrial Average, andNasdaq Composite, this represents a huge underperformance.\nBut according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.\nSarepta Therapeutics: Implied upside of 91%\nMany of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developerSarepta Therapeutics(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.\nSarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.\nHowever, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.  In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.\nThe Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.\nIntercept Pharmaceuticals: Implied upside of 97%\nIf you wanteven more upside potential, Wall Street would steer you toward small-capIntercept Pharmaceuticals(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.\nSimilar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.\nIntercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.\nOn the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.\nIf OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.\nIt's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.\nInovio Pharmaceuticals: Implied upside of 104%\nYet another biotech stock withbig-time upside potential, according to Wall Street, isInovio Pharmaceuticals(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.\nFor much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.\nUnfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.\nThere are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players likeJohnson & Johnson can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.\nThe other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.\nWith a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.","news_type":1},"isVote":1,"tweetType":1,"viewCount":68,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103587837,"gmtCreate":1619793694329,"gmtModify":1704272501779,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103587837","repostId":"1142070002","repostType":4,"isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109549025,"gmtCreate":1619706741967,"gmtModify":1704271152015,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>wth is wrong w this&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>wth is wrong w this&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$wth is wrong w this","images":[{"img":"https://static.tigerbbs.com/346d4f7efb93d43c0da3a3de3ea167db","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/109549025","isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":100592549,"gmtCreate":1619620128681,"gmtModify":1704726958253,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>-.-&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>-.-&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$-.-","images":[{"img":"https://static.tigerbbs.com/168921d010834c409f7de17324f9eeb8","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/100592549","isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":372203021,"gmtCreate":1619216686263,"gmtModify":1704721313245,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>I am worried&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>I am worried&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$I am worried","images":[{"img":"https://static.tigerbbs.com/b54bb47eae9c3d1f5bb2607d4a7cfa3e","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/372203021","isVote":1,"tweetType":1,"viewCount":209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":372200520,"gmtCreate":1619216534160,"gmtModify":1704721310790,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>Waiting for it to recover&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>Waiting for it to recover&nbsp;","text":"$ARK Innovation ETF(ARKK)$Waiting for it to recover","images":[{"img":"https://static.tigerbbs.com/3ebf96a80ddb9fc2608eda7e9369a1a2","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/372200520","isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":103561043,"gmtCreate":1619793893482,"gmtModify":1704272507362,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"&nbsp;Nice&nbsp;","listText":"&nbsp;Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/103561043","repostId":"1180690637","repostType":4,"repost":{"id":"1180690637","pubTimestamp":1619780056,"share":"https://ttm.financial/m/news/1180690637?lang=&edition=fundamental","pubTime":"2021-04-30 18:54","market":"us","language":"en","title":"EU says Apple’s App Store breaks competition rules after Spotify complaint","url":"https://stock-news.laohu8.com/highlight/detail?id=1180690637","media":"CNBC","summary":"Applehas “abused its dominant position” in the distribution of music streaming apps through its App Store, the European Commission said Friday.“The European Commission has informed Apple of its preliminary view that it distorted competition in the music streaming market as it abused its dominant position for the distribution of music streaming apps through its App Store,” it said in a “statement of objections” sent to Apple.On Friday, the EU said it took issue with the “mandatory use of Apple’s ","content":"<div>\n<p>Applehas “abused its dominant position” in the distribution of music streaming apps through its App Store, the European Commission said Friday.“The European Commission has informed Apple of its ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/30/eu-says-apples-app-store-breaches-competition-rules.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU says Apple’s App Store breaks competition rules after Spotify complaint</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU says Apple’s App Store breaks competition rules after Spotify complaint\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 18:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/30/eu-says-apples-app-store-breaches-competition-rules.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Applehas “abused its dominant position” in the distribution of music streaming apps through its App Store, the European Commission said Friday.“The European Commission has informed Apple of its ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/30/eu-says-apples-app-store-breaches-competition-rules.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.cnbc.com/2021/04/30/eu-says-apples-app-store-breaches-competition-rules.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1180690637","content_text":"Applehas “abused its dominant position” in the distribution of music streaming apps through its App Store, the European Commission said Friday.“The European Commission has informed Apple of its preliminary view that it distorted competition in the music streaming market as it abused its dominant position for the distribution of music streaming apps through its App Store,” it said in a “statement of objections” sent to Apple.The European Commission, the EU’s executive arm,opened an antitrust investigationinto the App Store last year, after the music streaming platformSpotifycomplained in 2019 about Apple’s license agreements. These mean that app developers have to pay a 30% commission on all subscription fees that come through the App Store.On Friday, the EU said it took issue with the “mandatory use of Apple’s own in-app purchase mechanism imposed on music streaming app developers to distribute their apps via Apple’s App Store.”App developers are also unable to inform users of alternative ways to purchase the same apps elsewhere — another issue the Commission said it was concerned with.In response, Apple said the EU’s case was the “opposite of fair competition,” according to a statement cited by Reuters.“Spotify has become the largest music subscription service in the world, and we’re proud of the role we played in that,” Apple said in the statement. “Once again, they want all the benefits of the App Store but don’t think they should have to pay anything for that.”A statement of objections is part of the formal process in an antitrust investigation, but it does not conclude the probe. Apple now has to reply to the Commission’s concerns either in writing or via a oral hearing.‘Apple is a gatekeeper’It comes after an e-book and audiobook distributor filed a similar complaint against Apple March 2020, while Epic Games —which is already locking horns with Apple in a U.S. legal battle— filed an antitrust complaint against the iPhone maker with the European Commission earlier this year.Margrethe Vestager, the head of competition policy in the EU, said app stores play a “central role” in today’s digital economy.“Our preliminary finding is that Apple is a gatekeeper to users of iPhones and iPads via the App Store. With Apple Music, Apple also competes with music streaming providers,” she said in a statement Friday.“By setting strict rules on the App store that disadvantage competing music streaming services, Apple deprives users of cheaper music streaming choices and distorts competition. This is done by charging high commission fees on each transaction in the App store for rivals and by forbidding them from informing their customers of alternative subscription options,” she added.Legal battlesThis is not the first investigation that the European Commission has brought against Apple.The commission decided in Septemberto take Apple and the Irish government to the highest court in the European Union for what Brussels deems unfair taxation practices.The EU ruled in 2016 that Apple had to repay 13 billion euros ($15.7 billion) in unpaid taxes to the Irish government, after the latter granted “undue tax benefits.”Apple and the Irish government have contested the decisionand the case is still in court.Hoping to overcome long legal battles and make its markets fairer, the European Union is working on new regulation that could ultimately impact many of the U.S. tech giants.TheDigital Markets Actis likely to end what’s known as self-preferencing — when, for instance, app search results in an Apple product prioritize those developed by the tech giant. The idea is to give smaller app developers the same chance of being found and chosen by consumers.The legislation is still being discussed by European lawmakers. But, apart from enforcing practical changes, it will also have the power to fine companies up to 10% of their worldwide annual turnover.","news_type":1},"isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":372203021,"gmtCreate":1619216686263,"gmtModify":1704721313245,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>I am worried&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>I am worried&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$I am worried","images":[{"img":"https://static.tigerbbs.com/b54bb47eae9c3d1f5bb2607d4a7cfa3e","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/372203021","isVote":1,"tweetType":1,"viewCount":209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156710833,"gmtCreate":1625236509022,"gmtModify":1703739165398,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Have been holding since Feb&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Have been holding since Feb&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$Have been holding since Feb","images":[{"img":"https://static.tigerbbs.com/570612cd6514f7b5cb9efcf94dc5c7f5","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156710833","isVote":1,"tweetType":1,"viewCount":249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":109549025,"gmtCreate":1619706741967,"gmtModify":1704271152015,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>wth is wrong w this&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>wth is wrong w this&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$wth is wrong w this","images":[{"img":"https://static.tigerbbs.com/346d4f7efb93d43c0da3a3de3ea167db","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/109549025","isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":372200520,"gmtCreate":1619216534160,"gmtModify":1704721310790,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>Waiting for it to recover&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>Waiting for it to recover&nbsp;","text":"$ARK Innovation ETF(ARKK)$Waiting for it to recover","images":[{"img":"https://static.tigerbbs.com/3ebf96a80ddb9fc2608eda7e9369a1a2","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/372200520","isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":344626028,"gmtCreate":1618407464064,"gmtModify":1704710330598,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CSCW\">$Color Star Technology Co. Ltd(CSCW)$</a>When will it go up ?&nbsp;","listText":"<a href=\"https://laohu8.com/S/CSCW\">$Color Star Technology Co. Ltd(CSCW)$</a>When will it go up ?&nbsp;","text":"$Color Star Technology Co. Ltd(CSCW)$When will it go up ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/344626028","isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345862782,"gmtCreate":1618301644546,"gmtModify":1704708793649,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/345862782","repostId":"1128427714","repostType":2,"repost":{"id":"1128427714","pubTimestamp":1618301339,"share":"https://ttm.financial/m/news/1128427714?lang=&edition=fundamental","pubTime":"2021-04-13 16:08","market":"us","language":"en","title":"9 Companies That Could Benefit From Incorporating NFTs","url":"https://stock-news.laohu8.com/highlight/detail?id=1128427714","media":"InvestorPlace","summary":"If NFTs go beyond fad status, they could offer lucrative revenue channels\nSource: Shutterstock\nI’m g","content":"<p>If NFTs go beyond fad status, they could offer lucrative revenue channels</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cd392daf45926894c19d7258feaf64ef\" tg-width=\"1024\" tg-height=\"576\"><span>Source: Shutterstock</span></p>\n<p>I’m going to start off with my strongest caveat to date: Non-fungible tokens or NFTs are not worth your time. In my view, talking up this new wave of “digital art” is irresponsible. Although this sector is tied to an innovative technology, the tokens themselves have almost zero provenance.</p>\n<p>I understand that NFTs are all the rage these days. But that in and of itself doesn’t justify this explosive industry. Consumer fads are incredibly fickle. I remember a joke that comedian Chris Rock once told an audience of celebrities — you’re here today and you’re gone today. Honestly, unless NFTs prove otherwise, you should truly exercise extreme caution and skepticism with this market.</p>\n<p>But there are still some reasons why you should pay attention to what’s going on in the space. So what exactly are NFTs? Great question. In a nutshell, these tokens take the qualities of cryptocurrencies — immutability and the underlying blockchain architecture’s verification process being the most important — and apply them to digital content, which can range from photographs, videos, gifs and even music. Essentially, it democratizes the otherwise rarefied world of fine art.</p>\n<p>Think of it this way. If you wanted to buy an original piece by Andy Warhol, you’re likely going to need deep connections to participate in fine art auction houses. With NFTs, people can own unique artwork or content of currently relevant celebrities which are uniquely stamped and verified by blockchain technology. Best of all, anyone can participate — you just need money.</p>\n<p>And that’s the appeal — anyone can buy NFTs or create them. That’s right. Starving artists now have another avenue to monetize their work. Certainly, this sector has some appeal. And these publicly traded companies ought to consider getting involved while the going’s hot.</p>\n<ul>\n <li><b>Amazon</b>&nbsp;(NASDAQ:<b><u>AMZN</u></b>)</li>\n <li><b>Shopify</b>&nbsp;(NYSE:<b><u>SHOP</u></b>)</li>\n <li><b>Spotify</b>&nbsp;(NYSE:<b><u>SPOT</u></b>)</li>\n <li><b>Facebook</b>&nbsp;(NASDAQ:<b><u>FB</u></b>)</li>\n <li><b>Etsy</b>&nbsp;(NASDAQ:<b><u>ETSY</u></b>)</li>\n <li><b>Pinterest</b>&nbsp;(NYSE:<b><u>PINS</u></b>)</li>\n <li><b>AT&amp;T</b>&nbsp;(NYSE:<b><u>T</u></b>)</li>\n <li><b>Liberty Media Formula One</b>&nbsp;(NASDAQ:<b><u>FWONK</u></b>)</li>\n <li><b>GameStop</b>&nbsp;(NYSE:<b><u>GME</u></b>)</li>\n</ul>\n<p>Now, please bear in mind that these stocks are not necessarily buy or sell ideas. Rather, these issuing companies may garner new opportunities if they participate in NFTs. Still, I will reiterate — buying these tokens directly is an incredibly risky venture.</p>\n<p><b>Companies That Could Benefit From NFTs: Amazon (AMZN)</b></p>\n<p>As I stated above, I believe NFTs are garbage and normally, I wouldn’t recommend companies get involved in them. However, Amazon is the world’s biggest vacuum cleaner, sucking up mom and pops everywhere and consolidating whatever it can under its massive corporate umbrella. Therefore, if the company ends up losing on its tokenized venture, I wouldn’t really care much.</p>\n<p>That said, I could be totally wrong about NFTs. In that case, Amazon may want to participate officially in this burgeoning sector. Indeed, by providing a marketplace for digital artwork and tailoring a platform that allows people to create their own tokenized content, the e-commerce giant could quickly dominate yet another market segment.</p>\n<p>If it happens, it’s probably not going to move the needle for AMZN stock. I like Amazon because it’s an economic inevitability, not because it’s a blockchain innovator.</p>\n<p><b>Shopify (SHOP)</b></p>\n<p>Indirectly, Shopify is already participating in NFTs. From a PYMNTS.com report, a “startup in San Francisco called the Real Items Foundation has developed a plugin for Shopify that will use blockchain technology to&nbsp;make sure items being sold on the site are authentic.”</p>\n<p>Essentially, the Real Items app is powered by a cloud-based blockchain architecture called TAM, which allows companies to create their own NFTs which are associated with actual physical items. From there, prospective customers can buy the items and scan it for NFT-based authentication.</p>\n<p>It’s a nifty idea and one that demonstrates the power of NFTs beyond their popular usage as a platform for crass consumerism. As with Amazon, I’m not sure if this will move the needle for SHOP stock. Still, the underlying management team ought to consider at least exploring the potential.</p>\n<p><b>Spotify (SPOT)</b></p>\n<p>A popular audio streaming and media services firm, Spotify is probably one of the natural beneficiaries of NFTs. As you know, Spotify aims to provide a happy medium for artists and entertainers, facilitating a global platform for their content while ensuring that these performers are paid for their efforts. It’s not a perfect system, of course, but it was better than the old days of the internet when people could just rip off music for free.</p>\n<p>But with the novel coronavirus pandemic disrupting the live touring industry, these same artists are now struggling with the loss of a pivotal revenue channel. That’s where NFTs come into the picture. By tokenizing music — yes, this is a thing — fans can now own unique, signature pieces of their favorite artists.</p>\n<p>Unlike other publicly traded companies, non-fungible tokens might actually move the needle for SPOT stock, so long as the tokens themselves stay relevant. We’ll see what happens.</p>\n<p><b>Facebook (FB)</b></p>\n<p>The world’s biggest social media network with 2.6 billion monthly active users, Facebook is truly a paradigm-shifting international phenomenon. And the company has embraced the cryptocurrency concept, working hard on its own cryptocurrency called Diem (formerly known as Libra). With that in mind, the company may also want to consider NFTs.</p>\n<p>Being that it’s a massive company, the venture into these new wave of tokens wouldn’t hurt FB stock if it failed. Also, Facebook absorbed multiple controversies in the past. If they support NFTs and the whole plot implodes, it’s not as if the incident is going to sully the company’s reputation. The CEO and the rest of the executive team is already doing a great job of that on their own.</p>\n<p>Plus, those billions of users could bring unprecedented credibility toward non-fungible tokens. Contextually, I see more upside and limited downside for Facebook.</p>\n<p><b>Etsy (ETSY)</b></p>\n<p>In many ways, I feel bad for suggesting NFTs to Etsy. If this digital art market goes belly up, it probably wouldn’t affect the alpha dogs that I mentioned, neither financially nor reputationally. However, I like Etsy and its mission to democratize arts and crafts (as in<i>real</i>arts and crafts) for the world to enjoy.</p>\n<p>In contrast, I find the art in tokenized art mostly self-serving and perhaps even predatory. Don’t send me hate mail regarding this opinion — I fully realize that this doesn’t apply to every NFT participant. But you got to look at some of the crap that’s sold as digital art. Any intellectually honest individual should see where I’m coming from.</p>\n<p>Anyways, if the NFT phenomenon makes a fool out of skeptics like me, then Etsy may want to wade into this arena. If anything, it will give the company’s platform an additional revenue channel to advantage.</p>\n<p><b>Pinterest (PINS)</b></p>\n<p>An image sharing and social media platform, Pinterest is one of the most popular Covid-19 winners. With millions of workers stuck at home due to lockdown initiatives, many found extra time on their hands. Thus, Pinterest provided a space where people could seek out their next purchasing idea. Furthermore, many if not most worker bees are still engaging remote operations.</p>\n<p>But at some point, the core business may start losing its luster. One of the powerful elements of NFTs is that they’re technologically and sentimentally tied to cryptocurrencies, which of course is massively popular with young investors. Therefore, if Pinterest finds some way of incorporating tokenized art into its business model, it could spark new demand for its equity shares.</p>\n<p><b>AT&amp;T (T)</b></p>\n<p>Although I’m a shareholder of AT&amp;T, I can’t help but find the company less than attractive, particularly for its customer service, which desperately needs improvement. Also, some of its internet services are lacking — I would know because I used to be a customer.</p>\n<p>But what really turns off analysts from T stock is the underlying company’s debt problem. As you know, AT&amp;T made some big bets on expanding its content entertainment portfolio and the Covid-19 crisis couldn’t have come at a worse time for the telecommunications giant. However, NFTs might save the day.</p>\n<p>While the iron is hot, AT&amp;T could potentially tokenize its popular entertainment brands or franchises. Yes, this is crass consumerism at its finest, but management needs to do something creative to help the company out of its rut.</p>\n<p><b>Liberty Media Formula One (FWONK)</b></p>\n<p>In the grand scheme of things, auto racing sometimes gets lost in the hyper-competitive world of professional sports. However, Liberty Media Formula One owns the namesake premiere auto racing championship. And this season is especially interesting because of its rookie class.</p>\n<p>First, you have Mick Schumacher, son of F1 legend Michael Schumacher, making his debut. Everyone will be eager to watch if the younger Schumacher can replicate the elder’s successes. Plus, with Lewis Hamilton likely to sweep the table again (come on, Max Verstappen!), it gives F1 fans something to look forward to. Do I smell a tokenized opportunity?</p>\n<p>Second, you have other forms of entertainment on opposite ends of the performance spectrum. Schumacher’s teammate, Nikita Mazepin, has garnered the nickname Nikita Maze-spin for his terrible on- and off-track antics. In contrast, Yuki Tsunoda has been an absolute delight, as the youngest driver in the F1 field delivering remarkable, veteran-like passes.</p>\n<p>Again, I see tokenizable opportunities everywhere, which could help FWONK stock.</p>\n<p><b>GameStop (GME)</b></p>\n<p>The company that started it all, GameStop at this point needs no introduction. Once left for dead as an irrelevant strip mall entity, GME stock shocked the world as investors on social media egged each other on to bid up shares. In doing so, the heavily shorted GME saw a short squeeze, causing much financial devastation to certain hedge funds … oops.</p>\n<p>While it has been an incredible ride to watch and participate in, you’ve got to figure that this craziness will soon fade. It always does. To GameStop’s credit, management is exploring new ideas to make the business relevant for the new generation of gamers. It could probably help its cause by embracing NFTs.</p>\n<p>Because the GameStop brand has become part of pop culture, it should consider monetizing this dynamic. This is sort of like disgraced Enron in reverse. I’m sure that years from now, people will still remember GameStop irrespective of whatever happens to GME stock.</p>\n<p>So, the time is now. Tokenize or die.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>9 Companies That Could Benefit From Incorporating NFTs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n9 Companies That Could Benefit From Incorporating NFTs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 16:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/9-companies-that-could-benefit-from-incorporating-nfts/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If NFTs go beyond fad status, they could offer lucrative revenue channels\nSource: Shutterstock\nI’m going to start off with my strongest caveat to date: Non-fungible tokens or NFTs are not worth your ...</p>\n\n<a href=\"https://investorplace.com/2021/04/9-companies-that-could-benefit-from-incorporating-nfts/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","SPOT":"Spotify Technology S.A.","PINS":"Pinterest, Inc.","T":"美国电话电报","FWONK":"Liberty Media Corporation Series C","AMZN":"亚马逊","SHOP":"Shopify Inc","ETSY":"Etsy, Inc."},"source_url":"https://investorplace.com/2021/04/9-companies-that-could-benefit-from-incorporating-nfts/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128427714","content_text":"If NFTs go beyond fad status, they could offer lucrative revenue channels\nSource: Shutterstock\nI’m going to start off with my strongest caveat to date: Non-fungible tokens or NFTs are not worth your time. In my view, talking up this new wave of “digital art” is irresponsible. Although this sector is tied to an innovative technology, the tokens themselves have almost zero provenance.\nI understand that NFTs are all the rage these days. But that in and of itself doesn’t justify this explosive industry. Consumer fads are incredibly fickle. I remember a joke that comedian Chris Rock once told an audience of celebrities — you’re here today and you’re gone today. Honestly, unless NFTs prove otherwise, you should truly exercise extreme caution and skepticism with this market.\nBut there are still some reasons why you should pay attention to what’s going on in the space. So what exactly are NFTs? Great question. In a nutshell, these tokens take the qualities of cryptocurrencies — immutability and the underlying blockchain architecture’s verification process being the most important — and apply them to digital content, which can range from photographs, videos, gifs and even music. Essentially, it democratizes the otherwise rarefied world of fine art.\nThink of it this way. If you wanted to buy an original piece by Andy Warhol, you’re likely going to need deep connections to participate in fine art auction houses. With NFTs, people can own unique artwork or content of currently relevant celebrities which are uniquely stamped and verified by blockchain technology. Best of all, anyone can participate — you just need money.\nAnd that’s the appeal — anyone can buy NFTs or create them. That’s right. Starving artists now have another avenue to monetize their work. Certainly, this sector has some appeal. And these publicly traded companies ought to consider getting involved while the going’s hot.\n\nAmazon (NASDAQ:AMZN)\nShopify (NYSE:SHOP)\nSpotify (NYSE:SPOT)\nFacebook (NASDAQ:FB)\nEtsy (NASDAQ:ETSY)\nPinterest (NYSE:PINS)\nAT&T (NYSE:T)\nLiberty Media Formula One (NASDAQ:FWONK)\nGameStop (NYSE:GME)\n\nNow, please bear in mind that these stocks are not necessarily buy or sell ideas. Rather, these issuing companies may garner new opportunities if they participate in NFTs. Still, I will reiterate — buying these tokens directly is an incredibly risky venture.\nCompanies That Could Benefit From NFTs: Amazon (AMZN)\nAs I stated above, I believe NFTs are garbage and normally, I wouldn’t recommend companies get involved in them. However, Amazon is the world’s biggest vacuum cleaner, sucking up mom and pops everywhere and consolidating whatever it can under its massive corporate umbrella. Therefore, if the company ends up losing on its tokenized venture, I wouldn’t really care much.\nThat said, I could be totally wrong about NFTs. In that case, Amazon may want to participate officially in this burgeoning sector. Indeed, by providing a marketplace for digital artwork and tailoring a platform that allows people to create their own tokenized content, the e-commerce giant could quickly dominate yet another market segment.\nIf it happens, it’s probably not going to move the needle for AMZN stock. I like Amazon because it’s an economic inevitability, not because it’s a blockchain innovator.\nShopify (SHOP)\nIndirectly, Shopify is already participating in NFTs. From a PYMNTS.com report, a “startup in San Francisco called the Real Items Foundation has developed a plugin for Shopify that will use blockchain technology to make sure items being sold on the site are authentic.”\nEssentially, the Real Items app is powered by a cloud-based blockchain architecture called TAM, which allows companies to create their own NFTs which are associated with actual physical items. From there, prospective customers can buy the items and scan it for NFT-based authentication.\nIt’s a nifty idea and one that demonstrates the power of NFTs beyond their popular usage as a platform for crass consumerism. As with Amazon, I’m not sure if this will move the needle for SHOP stock. Still, the underlying management team ought to consider at least exploring the potential.\nSpotify (SPOT)\nA popular audio streaming and media services firm, Spotify is probably one of the natural beneficiaries of NFTs. As you know, Spotify aims to provide a happy medium for artists and entertainers, facilitating a global platform for their content while ensuring that these performers are paid for their efforts. It’s not a perfect system, of course, but it was better than the old days of the internet when people could just rip off music for free.\nBut with the novel coronavirus pandemic disrupting the live touring industry, these same artists are now struggling with the loss of a pivotal revenue channel. That’s where NFTs come into the picture. By tokenizing music — yes, this is a thing — fans can now own unique, signature pieces of their favorite artists.\nUnlike other publicly traded companies, non-fungible tokens might actually move the needle for SPOT stock, so long as the tokens themselves stay relevant. We’ll see what happens.\nFacebook (FB)\nThe world’s biggest social media network with 2.6 billion monthly active users, Facebook is truly a paradigm-shifting international phenomenon. And the company has embraced the cryptocurrency concept, working hard on its own cryptocurrency called Diem (formerly known as Libra). With that in mind, the company may also want to consider NFTs.\nBeing that it’s a massive company, the venture into these new wave of tokens wouldn’t hurt FB stock if it failed. Also, Facebook absorbed multiple controversies in the past. If they support NFTs and the whole plot implodes, it’s not as if the incident is going to sully the company’s reputation. The CEO and the rest of the executive team is already doing a great job of that on their own.\nPlus, those billions of users could bring unprecedented credibility toward non-fungible tokens. Contextually, I see more upside and limited downside for Facebook.\nEtsy (ETSY)\nIn many ways, I feel bad for suggesting NFTs to Etsy. If this digital art market goes belly up, it probably wouldn’t affect the alpha dogs that I mentioned, neither financially nor reputationally. However, I like Etsy and its mission to democratize arts and crafts (as inrealarts and crafts) for the world to enjoy.\nIn contrast, I find the art in tokenized art mostly self-serving and perhaps even predatory. Don’t send me hate mail regarding this opinion — I fully realize that this doesn’t apply to every NFT participant. But you got to look at some of the crap that’s sold as digital art. Any intellectually honest individual should see where I’m coming from.\nAnyways, if the NFT phenomenon makes a fool out of skeptics like me, then Etsy may want to wade into this arena. If anything, it will give the company’s platform an additional revenue channel to advantage.\nPinterest (PINS)\nAn image sharing and social media platform, Pinterest is one of the most popular Covid-19 winners. With millions of workers stuck at home due to lockdown initiatives, many found extra time on their hands. Thus, Pinterest provided a space where people could seek out their next purchasing idea. Furthermore, many if not most worker bees are still engaging remote operations.\nBut at some point, the core business may start losing its luster. One of the powerful elements of NFTs is that they’re technologically and sentimentally tied to cryptocurrencies, which of course is massively popular with young investors. Therefore, if Pinterest finds some way of incorporating tokenized art into its business model, it could spark new demand for its equity shares.\nAT&T (T)\nAlthough I’m a shareholder of AT&T, I can’t help but find the company less than attractive, particularly for its customer service, which desperately needs improvement. Also, some of its internet services are lacking — I would know because I used to be a customer.\nBut what really turns off analysts from T stock is the underlying company’s debt problem. As you know, AT&T made some big bets on expanding its content entertainment portfolio and the Covid-19 crisis couldn’t have come at a worse time for the telecommunications giant. However, NFTs might save the day.\nWhile the iron is hot, AT&T could potentially tokenize its popular entertainment brands or franchises. Yes, this is crass consumerism at its finest, but management needs to do something creative to help the company out of its rut.\nLiberty Media Formula One (FWONK)\nIn the grand scheme of things, auto racing sometimes gets lost in the hyper-competitive world of professional sports. However, Liberty Media Formula One owns the namesake premiere auto racing championship. And this season is especially interesting because of its rookie class.\nFirst, you have Mick Schumacher, son of F1 legend Michael Schumacher, making his debut. Everyone will be eager to watch if the younger Schumacher can replicate the elder’s successes. Plus, with Lewis Hamilton likely to sweep the table again (come on, Max Verstappen!), it gives F1 fans something to look forward to. Do I smell a tokenized opportunity?\nSecond, you have other forms of entertainment on opposite ends of the performance spectrum. Schumacher’s teammate, Nikita Mazepin, has garnered the nickname Nikita Maze-spin for his terrible on- and off-track antics. In contrast, Yuki Tsunoda has been an absolute delight, as the youngest driver in the F1 field delivering remarkable, veteran-like passes.\nAgain, I see tokenizable opportunities everywhere, which could help FWONK stock.\nGameStop (GME)\nThe company that started it all, GameStop at this point needs no introduction. Once left for dead as an irrelevant strip mall entity, GME stock shocked the world as investors on social media egged each other on to bid up shares. In doing so, the heavily shorted GME saw a short squeeze, causing much financial devastation to certain hedge funds … oops.\nWhile it has been an incredible ride to watch and participate in, you’ve got to figure that this craziness will soon fade. It always does. To GameStop’s credit, management is exploring new ideas to make the business relevant for the new generation of gamers. It could probably help its cause by embracing NFTs.\nBecause the GameStop brand has become part of pop culture, it should consider monetizing this dynamic. This is sort of like disgraced Enron in reverse. I’m sure that years from now, people will still remember GameStop irrespective of whatever happens to GME stock.\nSo, the time is now. Tokenize or die.","news_type":1},"isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869909710,"gmtCreate":1632232781030,"gmtModify":1676530730510,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VOO\">$Vanguard S&amp;P 500 ETF(VOO)$</a>?","listText":"<a href=\"https://laohu8.com/S/VOO\">$Vanguard S&amp;P 500 ETF(VOO)$</a>?","text":"$Vanguard S&P 500 ETF(VOO)$?","images":[{"img":"https://static.tigerbbs.com/3f37c53f199580d28bc2cf8dd6a9a33a","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869909710","isVote":1,"tweetType":1,"viewCount":320,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172289826,"gmtCreate":1626962452465,"gmtModify":1703481468254,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>._. Have been holding since last year&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>._. Have been holding since last year&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$._. Have been holding since last year","images":[{"img":"https://static.tigerbbs.com/c807337cb85ef61d9bcd70f1b3161ee3","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172289826","isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":141974061,"gmtCreate":1625837266653,"gmtModify":1703749529799,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141974061","repostId":"2150980376","repostType":4,"repost":{"id":"2150980376","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625823947,"share":"https://ttm.financial/m/news/2150980376?lang=&edition=fundamental","pubTime":"2021-07-09 17:45","market":"sh","language":"en","title":"China cuts reserve requirements to support economic recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2150980376","media":"Reuters","summary":"BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that","content":"<p>BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that banks must hold as reserves, releasing around 1 trillion yuan ($154.19 billion) in long-term liquidity to help underpin an economic recovery that is starting to lose momentum.</p>\n<p>The People's Bank of China (PBOC) said on its website it would cut the reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> for all banks by 50 basis points (bps), effective on July 15.</p>\n<p>Banks that are subject to an RRR of 5% will be exempted from the new cut.</p>\n<p>The PBOC last cut the RRR in April last year, when the Chinese economy was still badly jolted by the coronavirus crisis. As the economy staged a strong rebound, aided by the surprisingly resilient exports, the PBOC had since shifted to a moderately tightening bias.</p>\n<p>The country's cabinet said on Wednesday that authorities will use timely cuts in RRR to help small firms cope with the negative impact from rising commodity prices, which came as a surprise to the market.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China cuts reserve requirements to support economic recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina cuts reserve requirements to support economic recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 17:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that banks must hold as reserves, releasing around 1 trillion yuan ($154.19 billion) in long-term liquidity to help underpin an economic recovery that is starting to lose momentum.</p>\n<p>The People's Bank of China (PBOC) said on its website it would cut the reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> for all banks by 50 basis points (bps), effective on July 15.</p>\n<p>Banks that are subject to an RRR of 5% will be exempted from the new cut.</p>\n<p>The PBOC last cut the RRR in April last year, when the Chinese economy was still badly jolted by the coronavirus crisis. As the economy staged a strong rebound, aided by the surprisingly resilient exports, the PBOC had since shifted to a moderately tightening bias.</p>\n<p>The country's cabinet said on Wednesday that authorities will use timely cuts in RRR to help small firms cope with the negative impact from rising commodity prices, which came as a surprise to the market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAAS":"中汽系统","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150980376","content_text":"BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that banks must hold as reserves, releasing around 1 trillion yuan ($154.19 billion) in long-term liquidity to help underpin an economic recovery that is starting to lose momentum.\nThe People's Bank of China (PBOC) said on its website it would cut the reserve requirement ratio $(RRR)$ for all banks by 50 basis points (bps), effective on July 15.\nBanks that are subject to an RRR of 5% will be exempted from the new cut.\nThe PBOC last cut the RRR in April last year, when the Chinese economy was still badly jolted by the coronavirus crisis. As the economy staged a strong rebound, aided by the surprisingly resilient exports, the PBOC had since shifted to a moderately tightening bias.\nThe country's cabinet said on Wednesday that authorities will use timely cuts in RRR to help small firms cope with the negative impact from rising commodity prices, which came as a surprise to the market.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157137043,"gmtCreate":1625571578982,"gmtModify":1703743981828,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Fml&nbsp;","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Fml&nbsp;","text":"$Alibaba(BABA)$Fml","images":[{"img":"https://static.tigerbbs.com/c4795ba762ebdf7bb475df060911a49d","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157137043","isVote":1,"tweetType":1,"viewCount":218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125241091,"gmtCreate":1624677099313,"gmtModify":1703843431131,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>LOLOL finally less than 10%&nbsp;","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>LOLOL finally less than 10%&nbsp;","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$LOLOL finally less than 10%","images":[{"img":"https://static.tigerbbs.com/6cf16fa79e2834e2fceb5d4dd2965904","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125241091","isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":103563501,"gmtCreate":1619793875303,"gmtModify":1704272506543,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103563501","repostId":"1189807124","repostType":4,"repost":{"id":"1189807124","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619791477,"share":"https://ttm.financial/m/news/1189807124?lang=&edition=fundamental","pubTime":"2021-04-30 22:04","market":"us","language":"en","title":"Amazon once rose 2.4%, setting a record high in intraday trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1189807124","media":"Tiger Newspress","summary":"Amazon once rose 2.4%, setting a record high in intraday trading.Here’s what analysts are saying abo","content":"<p>Amazon once rose 2.4%, setting a record high in intraday trading.</p><p><img src=\"https://static.tigerbbs.com/9b9f7378d5970cada2dc37de1aa76935\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p>Here’s what analysts are saying about Amazon tripling profits</p><p>Swiss Bank UBS raises its price target as the COVID-19 pandemic caused boom in demand for home deliveries, helping Amazon triple profits</p><p>The COVID-19 pandemic has caused a boom in demand for home deliveries, which has helped AmazonAMZN,+1.75%triple its first-quarter profits.</p><p>The online retailer’s stock has risen 46% the past year and some analysts think it could still have further to go.</p><p>Michael Lasser, an analyst at Swiss bank UBSUBS,-0.92%,has lifted his price target for Amazon to $4,350 from $4,150, writing: “With broad-based strength across e-commerce &amp; AWS, Amazon’s Q1 ’21 earnings report demonstrates why it remains the industry leader.”</p><p><b>Amazon’s pandemic profits top previous 3 years of earnings</b></p><p>Shyam Patil, an analyst from Susquehanna Financial Group, remains positive on Amazon.</p><p>“Business trends remain strong and should continue to do so throughout 2021,” he wrote. “Ultimately, we see AMZN as a long-term secular grower underpinned by its strong e-commerce, cloud, and advertising businesses.”</p><p><b>Should you buy Amazon stock? Analysts prefer it over other Big Tech companies</b></p><p>Trip Chowdhry, an analyst at Global Equities Research, noted the “solid results” and reiterated his view that Andy Jassy, who will replace founder Jeff Bezos as chief executive, will be a good boss.</p><p>Jassy currently runs Amazon Web Services, which Chowdhry says is benefiting from secular growth trends. “So many of you were panicked about CEO Transition,” he wrote. “Andy Jassy is a much better CEO than Jeff Bezos.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon once rose 2.4%, setting a record high in intraday trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon once rose 2.4%, setting a record high in intraday trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-30 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Amazon once rose 2.4%, setting a record high in intraday trading.</p><p><img src=\"https://static.tigerbbs.com/9b9f7378d5970cada2dc37de1aa76935\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p>Here’s what analysts are saying about Amazon tripling profits</p><p>Swiss Bank UBS raises its price target as the COVID-19 pandemic caused boom in demand for home deliveries, helping Amazon triple profits</p><p>The COVID-19 pandemic has caused a boom in demand for home deliveries, which has helped AmazonAMZN,+1.75%triple its first-quarter profits.</p><p>The online retailer’s stock has risen 46% the past year and some analysts think it could still have further to go.</p><p>Michael Lasser, an analyst at Swiss bank UBSUBS,-0.92%,has lifted his price target for Amazon to $4,350 from $4,150, writing: “With broad-based strength across e-commerce &amp; AWS, Amazon’s Q1 ’21 earnings report demonstrates why it remains the industry leader.”</p><p><b>Amazon’s pandemic profits top previous 3 years of earnings</b></p><p>Shyam Patil, an analyst from Susquehanna Financial Group, remains positive on Amazon.</p><p>“Business trends remain strong and should continue to do so throughout 2021,” he wrote. “Ultimately, we see AMZN as a long-term secular grower underpinned by its strong e-commerce, cloud, and advertising businesses.”</p><p><b>Should you buy Amazon stock? Analysts prefer it over other Big Tech companies</b></p><p>Trip Chowdhry, an analyst at Global Equities Research, noted the “solid results” and reiterated his view that Andy Jassy, who will replace founder Jeff Bezos as chief executive, will be a good boss.</p><p>Jassy currently runs Amazon Web Services, which Chowdhry says is benefiting from secular growth trends. “So many of you were panicked about CEO Transition,” he wrote. “Andy Jassy is a much better CEO than Jeff Bezos.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189807124","content_text":"Amazon once rose 2.4%, setting a record high in intraday trading.Here’s what analysts are saying about Amazon tripling profitsSwiss Bank UBS raises its price target as the COVID-19 pandemic caused boom in demand for home deliveries, helping Amazon triple profitsThe COVID-19 pandemic has caused a boom in demand for home deliveries, which has helped AmazonAMZN,+1.75%triple its first-quarter profits.The online retailer’s stock has risen 46% the past year and some analysts think it could still have further to go.Michael Lasser, an analyst at Swiss bank UBSUBS,-0.92%,has lifted his price target for Amazon to $4,350 from $4,150, writing: “With broad-based strength across e-commerce & AWS, Amazon’s Q1 ’21 earnings report demonstrates why it remains the industry leader.”Amazon’s pandemic profits top previous 3 years of earningsShyam Patil, an analyst from Susquehanna Financial Group, remains positive on Amazon.“Business trends remain strong and should continue to do so throughout 2021,” he wrote. “Ultimately, we see AMZN as a long-term secular grower underpinned by its strong e-commerce, cloud, and advertising businesses.”Should you buy Amazon stock? Analysts prefer it over other Big Tech companiesTrip Chowdhry, an analyst at Global Equities Research, noted the “solid results” and reiterated his view that Andy Jassy, who will replace founder Jeff Bezos as chief executive, will be a good boss.Jassy currently runs Amazon Web Services, which Chowdhry says is benefiting from secular growth trends. “So many of you were panicked about CEO Transition,” he wrote. “Andy Jassy is a much better CEO than Jeff Bezos.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103587581,"gmtCreate":1619793707443,"gmtModify":1704272502269,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103587581","repostId":"1165708828","repostType":4,"repost":{"id":"1165708828","pubTimestamp":1619792862,"share":"https://ttm.financial/m/news/1165708828?lang=&edition=fundamental","pubTime":"2021-04-30 22:27","market":"us","language":"en","title":"3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1165708828","media":"Motley Fool","summary":"For more than a year, patient investors have been handsomely rewarded. All three of the market's maj","content":"<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.</p>\n<p>Yet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in the<b>S&amp;P 500</b>,<b>Dow Jones Industrial Average</b>, and<b>Nasdaq Composite</b>, this represents a huge underperformance.</p>\n<p>But according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.</p>\n<p>Sarepta Therapeutics: Implied upside of 91%</p>\n<p>Many of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developer<b>Sarepta Therapeutics</b>(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.</p>\n<p>Sarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.</p>\n<p>However, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.&nbsp; In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.</p>\n<p>The Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.</p>\n<p>Intercept Pharmaceuticals: Implied upside of 97%</p>\n<p>If you wanteven more upside potential, Wall Street would steer you toward small-cap<b>Intercept Pharmaceuticals</b>(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.</p>\n<p>Similar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.</p>\n<p>Intercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.</p>\n<p>On the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.</p>\n<p>If OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.</p>\n<p>It's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.</p>\n<p>Inovio Pharmaceuticals: Implied upside of 104%</p>\n<p>Yet another biotech stock withbig-time upside potential, according to Wall Street, is<b>Inovio Pharmaceuticals</b>(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.</p>\n<p>For much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.</p>\n<p>Unfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.</p>\n<p>There are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players like<b>Johnson &amp; Johnson</b>&nbsp;can produce up to 3 billion doses for the global market this year. As a reminder, J&amp;J's vaccine is a single-dose treatment.</p>\n<p>The other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.</p>\n<p>With a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 22:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165708828","content_text":"For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.\nYet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in theS&P 500,Dow Jones Industrial Average, andNasdaq Composite, this represents a huge underperformance.\nBut according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.\nSarepta Therapeutics: Implied upside of 91%\nMany of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developerSarepta Therapeutics(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.\nSarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.\nHowever, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.  In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.\nThe Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.\nIntercept Pharmaceuticals: Implied upside of 97%\nIf you wanteven more upside potential, Wall Street would steer you toward small-capIntercept Pharmaceuticals(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.\nSimilar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.\nIntercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.\nOn the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.\nIf OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.\nIt's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.\nInovio Pharmaceuticals: Implied upside of 104%\nYet another biotech stock withbig-time upside potential, according to Wall Street, isInovio Pharmaceuticals(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.\nFor much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.\nUnfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.\nThere are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players likeJohnson & Johnson can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.\nThe other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.\nWith a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.","news_type":1},"isVote":1,"tweetType":1,"viewCount":68,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103587837,"gmtCreate":1619793694329,"gmtModify":1704272501779,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103587837","repostId":"1142070002","repostType":4,"repost":{"id":"1142070002","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619792975,"share":"https://ttm.financial/m/news/1142070002?lang=&edition=fundamental","pubTime":"2021-04-30 22:29","market":"us","language":"en","title":"NIO rose more than 5%, after falling nearly 4% before","url":"https://stock-news.laohu8.com/highlight/detail?id=1142070002","media":"Tiger Newspress","summary":"NIO Earnings Looked a Lot Like Ford’s. What to Know.Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.NIO  is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales.","content":"<p>NIO rose more than 5%, after falling nearly 4% before.</p><p><img src=\"https://static.tigerbbs.com/80881ae9e6de48ac5e3733583db3ba9e\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><b>NIO Earnings Looked a Lot Like Ford’s. What to Know.</b></p><p>Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.</p><p>NIO (ticker: NIO) is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.</p><p>NIO lost&nbsp;23 cents&nbsp;a share on an adjusted, non-GAAP basis, from $1.2 billion in sales. Wall Street was looking for a comparable 84 cent loss from $1.1 billion in sales. NIO’s corporate gross profit margin came in at 19.5%, about 3 percentage points better than analysts projected and up from negative 12% a year ago. First quarter results look solid.</p><p>The stock isn’t moving though. NIO reported numbers at 5:30 p.m. eastern time and not a lot of stock is trading after hours. NIO shares closed down 5.3% in Thursday trading. TheS&amp;P 500&nbsp;and&nbsp;Dow Jones Industrial Average&nbsp;rose about&nbsp; 0.7%.</p><p>“NIO started the year of 2021 with a new quarterly delivery record of 20,060 vehicles in the first quarter,” said CEO William Bin Li in the company’s news release. “The overall demand for our products continues to be quite strong, but the supply chain is still facing significant challenges due to the semiconductor shortage.”</p><p>Management called the chip situation “very severe” on its conference call and projected 21,000 to 22,000 vehicle deliveries for the second quarter and sales of about $1.3 billion. The Street is projecting $1.2 billion in sales. But the unit delivery guidance is a little lower than Deutsche Bank analyst Edison Yu had expected.</p><p>For the full year, Yu is modeling 95,000 deliveries. With about 42,000 deliveries likely for the first half of 2021, the resolution of the global chip shortage will go a long way to deciding whether or not NIO can reach Yu’s number.</p><p>Yu rates NIO shares Buy and has a $60 price target for the stock.</p><p>The overall quarter feels a little like&nbsp;Ford Motor‘s (F) quarter, which was&nbsp;reported Wednesday. Ford reported sales and earnings far better than Wall Street projected. Unit volumes were below the company’s internal projections, but improving vehicle mix boosted sales beyond Street projections. Ford prioritized making higher-end vehicles in the face of limited chip supply. Looking ahead, Ford said the impact of the chip shortage would be at the high end of the company’s initial $1 billion to $2.5 billion cost guidance.</p><p>Ford stock close down 9.4% Thursday, the day after the Wednesday evening report. The NIO second-quarter guidance isn’t as surprising as Ford’s. And NIO doesn’t have full-year guidance. But calling NIO’s stock price reaction is difficult.</p><p>Ford trades for less than 7 times estimated 2022 earnings. NIO is expected to become profitable on a full-year basis in 2022. What’s more, NIO is worth about 50% more than Ford.</p><p>NIO’s conference call wrapped up about 10 p.m. eastern time. After the chip shortage, analysts focused questions on EV competition in China and NIO’s production expansion. NIO is putting in place&nbsp;capacity to produce&nbsp;hundreds of thousands of vehicles in coming years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO rose more than 5%, after falling nearly 4% before</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO rose more than 5%, after falling nearly 4% before\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-30 22:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NIO rose more than 5%, after falling nearly 4% before.</p><p><img src=\"https://static.tigerbbs.com/80881ae9e6de48ac5e3733583db3ba9e\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><b>NIO Earnings Looked a Lot Like Ford’s. What to Know.</b></p><p>Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.</p><p>NIO (ticker: NIO) is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.</p><p>NIO lost&nbsp;23 cents&nbsp;a share on an adjusted, non-GAAP basis, from $1.2 billion in sales. Wall Street was looking for a comparable 84 cent loss from $1.1 billion in sales. NIO’s corporate gross profit margin came in at 19.5%, about 3 percentage points better than analysts projected and up from negative 12% a year ago. First quarter results look solid.</p><p>The stock isn’t moving though. NIO reported numbers at 5:30 p.m. eastern time and not a lot of stock is trading after hours. NIO shares closed down 5.3% in Thursday trading. TheS&amp;P 500&nbsp;and&nbsp;Dow Jones Industrial Average&nbsp;rose about&nbsp; 0.7%.</p><p>“NIO started the year of 2021 with a new quarterly delivery record of 20,060 vehicles in the first quarter,” said CEO William Bin Li in the company’s news release. “The overall demand for our products continues to be quite strong, but the supply chain is still facing significant challenges due to the semiconductor shortage.”</p><p>Management called the chip situation “very severe” on its conference call and projected 21,000 to 22,000 vehicle deliveries for the second quarter and sales of about $1.3 billion. The Street is projecting $1.2 billion in sales. But the unit delivery guidance is a little lower than Deutsche Bank analyst Edison Yu had expected.</p><p>For the full year, Yu is modeling 95,000 deliveries. With about 42,000 deliveries likely for the first half of 2021, the resolution of the global chip shortage will go a long way to deciding whether or not NIO can reach Yu’s number.</p><p>Yu rates NIO shares Buy and has a $60 price target for the stock.</p><p>The overall quarter feels a little like&nbsp;Ford Motor‘s (F) quarter, which was&nbsp;reported Wednesday. Ford reported sales and earnings far better than Wall Street projected. Unit volumes were below the company’s internal projections, but improving vehicle mix boosted sales beyond Street projections. Ford prioritized making higher-end vehicles in the face of limited chip supply. Looking ahead, Ford said the impact of the chip shortage would be at the high end of the company’s initial $1 billion to $2.5 billion cost guidance.</p><p>Ford stock close down 9.4% Thursday, the day after the Wednesday evening report. The NIO second-quarter guidance isn’t as surprising as Ford’s. And NIO doesn’t have full-year guidance. But calling NIO’s stock price reaction is difficult.</p><p>Ford trades for less than 7 times estimated 2022 earnings. NIO is expected to become profitable on a full-year basis in 2022. What’s more, NIO is worth about 50% more than Ford.</p><p>NIO’s conference call wrapped up about 10 p.m. eastern time. After the chip shortage, analysts focused questions on EV competition in China and NIO’s production expansion. NIO is putting in place&nbsp;capacity to produce&nbsp;hundreds of thousands of vehicles in coming years.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142070002","content_text":"NIO rose more than 5%, after falling nearly 4% before.NIO Earnings Looked a Lot Like Ford’s. What to Know.Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.NIO (ticker: NIO) is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales. Wall Street was looking for a comparable 84 cent loss from $1.1 billion in sales. NIO’s corporate gross profit margin came in at 19.5%, about 3 percentage points better than analysts projected and up from negative 12% a year ago. First quarter results look solid.The stock isn’t moving though. NIO reported numbers at 5:30 p.m. eastern time and not a lot of stock is trading after hours. NIO shares closed down 5.3% in Thursday trading. TheS&P 500 and Dow Jones Industrial Average rose about  0.7%.“NIO started the year of 2021 with a new quarterly delivery record of 20,060 vehicles in the first quarter,” said CEO William Bin Li in the company’s news release. “The overall demand for our products continues to be quite strong, but the supply chain is still facing significant challenges due to the semiconductor shortage.”Management called the chip situation “very severe” on its conference call and projected 21,000 to 22,000 vehicle deliveries for the second quarter and sales of about $1.3 billion. The Street is projecting $1.2 billion in sales. But the unit delivery guidance is a little lower than Deutsche Bank analyst Edison Yu had expected.For the full year, Yu is modeling 95,000 deliveries. With about 42,000 deliveries likely for the first half of 2021, the resolution of the global chip shortage will go a long way to deciding whether or not NIO can reach Yu’s number.Yu rates NIO shares Buy and has a $60 price target for the stock.The overall quarter feels a little like Ford Motor‘s (F) quarter, which was reported Wednesday. Ford reported sales and earnings far better than Wall Street projected. Unit volumes were below the company’s internal projections, but improving vehicle mix boosted sales beyond Street projections. Ford prioritized making higher-end vehicles in the face of limited chip supply. Looking ahead, Ford said the impact of the chip shortage would be at the high end of the company’s initial $1 billion to $2.5 billion cost guidance.Ford stock close down 9.4% Thursday, the day after the Wednesday evening report. The NIO second-quarter guidance isn’t as surprising as Ford’s. And NIO doesn’t have full-year guidance. But calling NIO’s stock price reaction is difficult.Ford trades for less than 7 times estimated 2022 earnings. NIO is expected to become profitable on a full-year basis in 2022. What’s more, NIO is worth about 50% more than Ford.NIO’s conference call wrapped up about 10 p.m. eastern time. After the chip shortage, analysts focused questions on EV competition in China and NIO’s production expansion. NIO is putting in place capacity to produce hundreds of thousands of vehicles in coming years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141977194,"gmtCreate":1625837339818,"gmtModify":1703749531267,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141977194","repostId":"2150376848","repostType":4,"repost":{"id":"2150376848","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625821544,"share":"https://ttm.financial/m/news/2150376848?lang=&edition=fundamental","pubTime":"2021-07-09 17:05","market":"sh","language":"en","title":"China June new bank loans rise to 2.12 trln yuan, beat expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2150376848","media":"Reuters","summary":"BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loa","content":"<p>BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loans in June, up from May and exceeding analysts' expectations.</p>\n<p>Analysts polled by Reuters had predicted new yuan loans would rise to 1.8 trillion yuan in June from 1.5 trillion yuan the previous month and against 1.81 trillion yuan a year earlier.</p>\n<p>Broad M2 money supply grew 8.6% from a year earlier, central bank data showed on Friday, also above estimates of 8.2% forecast in the Reuters poll. M2 grew 8.3% in May from a year ago.</p>\n<p>Outstanding yuan loans grew 12.3% from a year earlier compared with 12.2% growth in May. Analysts had expected 12.1% growth.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China June new bank loans rise to 2.12 trln yuan, beat expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina June new bank loans rise to 2.12 trln yuan, beat expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loans in June, up from May and exceeding analysts' expectations.</p>\n<p>Analysts polled by Reuters had predicted new yuan loans would rise to 1.8 trillion yuan in June from 1.5 trillion yuan the previous month and against 1.81 trillion yuan a year earlier.</p>\n<p>Broad M2 money supply grew 8.6% from a year earlier, central bank data showed on Friday, also above estimates of 8.2% forecast in the Reuters poll. M2 grew 8.3% in May from a year ago.</p>\n<p>Outstanding yuan loans grew 12.3% from a year earlier compared with 12.2% growth in May. Analysts had expected 12.1% growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAAS":"中汽系统"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150376848","content_text":"BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loans in June, up from May and exceeding analysts' expectations.\nAnalysts polled by Reuters had predicted new yuan loans would rise to 1.8 trillion yuan in June from 1.5 trillion yuan the previous month and against 1.81 trillion yuan a year earlier.\nBroad M2 money supply grew 8.6% from a year earlier, central bank data showed on Friday, also above estimates of 8.2% forecast in the Reuters poll. M2 grew 8.3% in May from a year ago.\nOutstanding yuan loans grew 12.3% from a year earlier compared with 12.2% growth in May. Analysts had expected 12.1% growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141977009,"gmtCreate":1625837311701,"gmtModify":1703749530451,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Oh noooo","listText":"Oh noooo","text":"Oh noooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141977009","repostId":"2150537517","repostType":4,"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141974483,"gmtCreate":1625837295442,"gmtModify":1703749531105,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Kkkk&nbsp;","listText":"Kkkk&nbsp;","text":"Kkkk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141974483","repostId":"1113072261","repostType":4,"isVote":1,"tweetType":1,"viewCount":361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":156743989,"gmtCreate":1625238350241,"gmtModify":1703739237136,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Sobs&nbsp;","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Sobs&nbsp;","text":"$Alibaba(BABA)$Sobs","images":[{"img":"https://static.tigerbbs.com/b899ec0eacf287348884e35b865d69c7","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156743989","isVote":1,"tweetType":1,"viewCount":286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125058705,"gmtCreate":1624637774207,"gmtModify":1703842566402,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560508329513236","authorIdStr":"3560508329513236"},"themes":[],"htmlText":"Wow&nbsp;","listText":"Wow&nbsp;","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125058705","repostId":"2146079086","repostType":4,"isVote":1,"tweetType":1,"viewCount":61,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}